Zessly is considered a biosimilar to Remicade. Zessly treatment is administered by healthcare professionals only, qualified to administer infusions and detect related treatment issues. Physicians prescribing Zessly must have experience with rheumatoid arthritis, IBS, psoriasis and other conditions treated with infliximab, the active ingredient of Zessly.
This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees celsius, and contact the pharmacy immediately.